Pharma BD Deal Intelligence

Apotex Inc. / Cumberland Pharmaceuticals branded U.S. commercial business

2026 · Asset Purchase · $100M · Pending

Announcement Sentiment

Strongly positive

Cumberland Pharmaceuticals (CPIX) agreed to sell its branded U.S. commercial business to an Apotex affiliate for $100M cash, retaining its ifetroban pipeline (DMD cardiomyopathy and systemic sclerosis programs). Subject to Cumberland shareholder approval.

Key facts

Announced Apr 23, 2026
Deal value $100M
Deal type Asset Purchase
Therapeutic area specialty/hospital pharmaceuticals
Indications specialty/hospital pharmaceuticals
Key assets Cumberland branded U.S. specialty portfolio (Caldolor, Vibativ, Kristalose, Acetadote, Sancuso and other FDA-approved brands)

See the full interactive analysis, sources & comparables →

← Browse all deals · How we score deals